CEO and Co-founder
RS&RS Scientific LTD
RS&RS Scientific develops inhalable, targeted gene therapies specifically for lung cancer treatment. This approach delivers precise genetic tools directly to the tumor site to improve efficacy and reduce the toxicity associated with conventional cancer treatments. The company focuses on molecular innovation and practical delivery systems to advance precision oncology.
- Artificial Intelligence
- Biotechnology
- Healthcare Technology
Updated yesterday
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Product
Features
- RS&RS Scientific develops inhalable, targeted gene therapies specifically for lung cancer treatment. This approach delivers precise genetic tools directly to the tumor site to improve efficacy and reduce the toxicity associated with conventional cancer treatments. The company focuses on molecular innovation and practical delivery systems to advance precision oncology.